Kaletra
Product Images NDC 66336-624

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Kaletra (NDC 66336-624). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dispensing Solutions, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 66336-0624-xx (Ndc 66336 0624 Xx Abbott)

Ndc 66336-0624-xx (Ndc 66336 0624 Xx      Abbott)
Kaletra 200 mg/50 mg oral tablet label featuring drug information including active ingredients lopinavir 200 mg and ritonavir 50 mg. The label displays the NDC 66336-0624-XX, directions to take tablets whole, warnings about possible side effects, storage conditions, and the Dispensing Solutions, Inc. logo, manufacturer located in Santa Ana, CA.*
FDA Label Image

Body Surface Area Equation. (Kaletra Tablets Bsacalculation)

Body Surface Area Equation. (Kaletra Tablets Bsacalculation)
Chemical structure diagram illustrating the formula for calculating body surface area (BSA) in square meters (m²), based on height in centimeters (Ht) and weight in kilograms (Wt). This is a mathematical representation rather than a pharmaceutical product image.*
FDA Label Image

Figure Displays Steady-state Plasma Concentrations For Lopinavir And Ritonavir. (Kaletra Tablets Oral Figure1)

Figure Displays Steady-state Plasma Concentrations For Lopinavir And Ritonavir. (Kaletra Tablets Oral Figure1)
A line graph showing the concentration of Lopinavir and Ritonavir in micrograms per milliliter (µg/mL) over a 12-hour period. Lopinavir is represented with solid circles, Ritonavir with open circles, and the 95% confidence interval with dashed lines. The graph illustrates changes in drug concentration versus time.*
FDA Label Image

Chemical Structure For Lopinavir. (Kaletra Tablets Oral Structure1)

Chemical Structure For Lopinavir. (Kaletra Tablets Oral Structure1)
Chemical structure of the active ingredient in Kaletra. The diagram shows the detailed molecular bonds and atom arrangements typical for this pharmaceutical compound.*
FDA Label Image

Chemical Structure For Ritonavir. (Kaletra Tablets Oral Structure2)

Chemical Structure For Ritonavir. (Kaletra Tablets Oral Structure2)
Chemical structure of the active ingredient in Kaletra as provided by Dispensing Solutions, Inc., showing the detailed molecular formula with various functional groups and stereochemistry.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.